Recente publicaties
- launch Alig, S.K., Shahrokh Esfahani, M., Garofalo, A., Li, M.Y., Rossi, C., Flerlage, T., Flerlage, J.E., Adams, R., Binkley, M.S., Shukla, N., Jin, M.C., Olsen, M., Telenius, A., Mutter, J.A., Schroers-Martin, J.G., Sworder, B.J., Rai, S., King, D.A., Schultz, A., Bögeholz, J., Su, S., Kathuria, K.R., Liu, C.L., Kang, X., Strohband, M.J., Langfitt, D., Pobre-Piza, K.F., Surman, S., Tian, F., Spina, V., Tousseyn, T., Buedts, L., Hoppe, R., Natkunam, Y., Fornecker, L-M., Castellino, S.M., Advani, R., Rossi, D., Lynch, R., Ghesquières, H., Casasnovas, O., Kurtz, D.M., Marks, L.J., Link, M.P., André, M., Vandenberghe, P., Steidl, C., Diehn, M., Alizadeh, A.A. (2024). Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature, 625 (7996), 778-787. doi: 10.1038/s41586-023-06903-x
- launch Rengifo, L.Y., Smits, S., Boeckx, N., Michaux, L., Vandenberghe, P., Dewaele, B. with Dewaele, B. (corresp. author) (2023). Shallow whole-genome sequencing of bone marrow aspirates in myelodysplastic neoplasms: A retrospective comparison with cytogenetics. GENES CHROMOSOMES & CANCER, 62 (11), 663-671. doi: 10.1002/gcc.23183
- launch Van Thillo, Q., Dewaele, B., De Bie, J., Michaux, L., Devos, T., Vandenberghe, P. with Vandenberghe, P. (corresp. author) (2023). Revisiting a case of idiopathic hypereosinophilic syndrome with novel molecular techniques identifies a second case of a myeloid/lymphoid neoplasm with a SART3::PDGFRB fusion. BRITISH JOURNAL OF HAEMATOLOGY, 202 (1), E7-E10. doi: 10.1111/bjh.18849
- launch Lierman, E., Smits, S., Debackere, K., Andre, M., Michaux, L., Vandenberghe, P. with Vandenberghe, P. (corresp. author) (2023). t(9;12)(q22;p13) ETV6::SYK: A new recurrent cytogenetic aberration and tyrosine kinase gene fusion in myeloid or lymphoid neoplasms associated with eosinophilia. BRITISH JOURNAL OF HAEMATOLOGY, 200 (5), 665-668. doi: 10.1111/bjh.18569
- launch Messiaen, J., Uyttebroeck, A., Michaux, L., Vandenberghe, P., Boeckx, N., Jacobs, S.A. with Jacobs, S.A. (corresp. author) (2023). t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report. MOLECULAR AND CLINICAL ONCOLOGY, 18 (3), Art.No. ARTN 18. doi: 10.3892/mco.2023.2614 via repository
- launch Provez, L., Putteman, T., Landfors, M., Roels, J., Reunes, L., T'Sas, S., Van Loocke, W., Lintermans, B., De Coninck, S., Thenoz, M., Sleeckx, W., Mackowska-Maslak, N., Taghon, T., Mansour, M.R., Farah, N., Norga, K., Vandenberghe, P., Kotecha, R.S., Goossens, S., Degerman, S., De Smedt, R., Van Vlierberghe, P. with Provez, L. (corresp. author) (2023). Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma. CANCERS, 15 (3), Art.No. ARTN 647. doi: 10.3390/cancers15030647 via repository
- launch Valent, P., Klion, A.D., Roufosse, F., Simon, D., Metzgeroth, G., Leiferman, K.M., Schwaab, J., Butterfield, J.H., Sperr, W.R., Sotlar, K., Vandenberghe, P., Hoermann, G., Haferlach, T., Moriggl, R., George, T., Akin, C., Bochner, B.S., Gotlib, J., Reiter, A., Horny, H-P., Arock, M., Simon, H-U., Gleich, G.J. with Valent, P. (corresp. author) (2023). Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes. ALLERGY, 78 (1), 47-59. doi: 10.1111/all.15544 via repository
- launch Buedts, L., Vandenberghe, P. (sup.) (2022). Circulating cell-free DNA: a novel gateway to the genome of Hodgkin lymphoma.
- launch Garofalo, A., Alig, S.K., Schroers-Martin, J., Shyam, R.M., Olsen, M., Kurtz, D.M., Rossi, C., Schultz, A., Kathuria, K.R., Liu, C.L., Spina, V., Flerlage, J.E., Castellino, S.M., Advani, R.H., Rossi, D., Lynch, R.C., Casasnovas, O., Marks, L.J., Link, M.P., Andre, M., Vandenberghe, P., Steidl, C., Diehn, M., Alizadeh, A.A. (2022). Viral cfDNA Profiling Reveals Distinct EBV Subtypes and Stratifies Risk in Hodgkin Lymphomas. In: BLOOD: vol. 140, (1318-1319). Presented at the 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), LA, New Orleans, 10 Dec 2022-13 Dec 2022. doi: 10.1182/blood-2022-159230
- launch Cortes, J.E., Saikia, T., Kim, D-W., Alvarado, Y., Nicolini, F.E., Rathnam, K., Khattry, N., Punatar, S., Apperley, J.F., Charbonnier, A., Deininger, M., de Lavallade, H., Granacher, N., Gambacorti-Passerini, C., Lucchesi, A., Mauro, M., Vandenberghe, P., Verhoef, G., Whiteley, A.R., Nag, A., Apte, S., Yao, S-L., Inamdar, S., Dillu, R.I., Sreenivasan, J., Chimote, G. (2022). Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph plus CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy. In: BLOOD: vol. 140. Presented at the 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), LA, New Orleans, 10 Dec 2022-13 Dec 2022. doi: 10.1182/blood-2022-166452
- E03X4A Advanced Study of Hematology
- E03X5A Probleemoplossend vermogen en vaardigheden in de hematologie
- E03X8A Praktische oefeningen in EBM in de hematologie
- E03X9A Wetenschappelijke verdieping in de hematologie
- E0C12A Hemato-oncologie
- E0AM6A Probleemoplossend vermogen in de interne geneeskunde, deel 1
- E0AX2A Probleemoplossend vermogen in de interne geneeskunde, deel 2
- E0BB2A Probleemoplossend vermogen in de interne geneeskunde, deel 3
- E0BK9A Vaardigheden in de hematologie, deel 1
- E0BL8A Vaardigheden in de hematologie, deel 2
- E0BR8A Probleemoplossend vermogen in de hematologie, deel 1
- E0BT6A Probleemoplossend vermogen in de hematologie, deel 2
- E0BW4A Probleemoplossend vermogen in de hematologie, deel 3
- E0CL4A Communicatie in de hematologie
- E0CO8A Wetenschappelijke verdieping in de hematologie, deel 1
- E0CP9A Wetenschappelijke verdieping in de hematologie, deel 2
- E0CV4A Evidence-based medicine voor hematologie
- E0DI9A Aanvullingen in de hematologie